REN and diabetes mellitus: The current study findings are likely to be related to the fact that those with diabetes were more likely to be on evidence-based treatment on admission – that is beta blockers, renin-angiotensin blockade and statins, as well as aldosterone antagonists, which have all been demonstrated to have a mortality benefit.